New Moderna CFO Lasts One Day
He departed the same day his former employer’s regulatory filings indicated an investigation into misuse of incentives to manipulate financial performance.
Moderna Inc. CFO Jorge Gomez left the Covid-19 vaccine maker after just one day, following an internal investigation at his former employer.
Gomez’s departure Tuesday follows Dentsply Sirona Inc.’s disclosure of an internal investigation of financial reporting matters, Moderna said. Gomez was Dentsply Sirona’s CFO for almost three years. Moderna’s recently retired finance chief, David Meline, will serve in the role while the company searches for a new CFO, the vaccine maker said Wednesday.
Moderna hired Gomez in April to replace Meline, 64, with CEO Stephane Bancel citing his passion for sustainability, which aligned with the company’s vision of corporate responsibility as a key part of its mission.
Gomez, 54, will receive 12 months’ salary—totaling $700,000—as severance pay but will forfeit his signing bonus, bonus eligibility, and eligibility for new hire equity awards, Moderna said in a securities filing.
Moderna shares fell 1.2 percent at 10:12 a.m. in New York.
Dentsply Sirona, a maker of dental instruments and systems, said Tuesday that its audit and finance committee is investigating allegations around the company’s use of incentives to sell products to distributors and other actions to achieve executive compensation targets.
Moderna said it learned about the probe through Dentsply’s regulatory filing on Tuesday.
—With assistance from Robert Langreth.
Copyright 2022 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.